GSK India seeks shareholder nod for director appointments

GlaxoSmithKline Pharmaceuticals India (GSK) [BSE: GLAXO] has initiated a postal ballot process to seek shareholder approval for key leadership decisions. The company is seeking re-appointment of Mr. Juby Chandy as Whole-time Director & Chief Financial Officer for a two-year term starting April 1, 2025. Shareholders will also vote on the appointment of Mr. Somasundaram Palamadairamaswamy and Mr. Anup Wadhawan as Independent Directors, each for a five-year term beginning March 26, 2025.